ExpressionEdits is a biotechnology company that redesigns synthetic DNA instructions using AI, focusing on protein expression.
ExpressionEdits has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
ExpressionEdits's investors include Octopus Ventures, redalpine, BlueYard Capital, Acequia Capital (AceCap), Wilbe.
ExpressionEdits is headquartered in Haverhill, United Kingdom.
ExpressionEdits is a biotechnology company that redesigns synthetic DNA instructions using AI, focusing on protein expression.
ExpressionEdits is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ExpressionEdits — Funding & Investors." VCBacked, May 29, 2024, https://www.vcbacked.co/company/expressionedits. Accessed November 11, 2026.
VCBacked. (2024). ExpressionEdits — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/expressionedits
{{cite web |title=ExpressionEdits — Funding & Investors |url=https://www.vcbacked.co/company/expressionedits |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ExpressionEdits? Request a listing update